Dashboard
Manage Tickers

CHE CHEMED CORP

NYSE chemed.com


$ 436.54 $ -10.44 (-2.34 %)    

Friday, 14-Nov-2025 15:54:10 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 611.20 $ 0.00 (0 %)
DIA $ 471.59 $ 0.00 (0 %)
SPY $ 673.29 $ 0.00 (0 %)
TLT $ 89.16 $ 0.00 (0 %)
GLD $ 375.06 $ 0.00 (0 %)
$ 435.56
$ 445.20
$ 0.00 x 0
$ 0.00 x 0
-- - --
$ 407.30 - $ 621.35
127,847
na
6.16B
$ 0.44
$ 22.10
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-31-2025 09-30-2025 10-Q
2 07-31-2025 06-30-2025 10-Q
3 04-28-2025 03-31-2025 10-Q
4 02-28-2025 01-01-1970 10-K
5 11-01-2024 09-30-2024 10-Q
6 07-26-2024 06-30-2024 10-Q
7 04-29-2024 03-31-2024 10-Q
8 02-29-2024 12-31-2023 10-K
9 10-27-2023 09-30-2023 10-Q
10 07-28-2023 06-30-2023 10-Q
11 04-28-2023 03-31-2023 10-Q
12 02-27-2023 12-31-2022 10-K
13 11-02-2022 09-30-2022 10-Q
14 07-29-2022 06-30-2022 10-Q
15 04-29-2022 03-31-2022 10-Q
16 02-28-2022 12-31-2021 10-K
17 11-01-2021 09-30-2021 10-Q
18 07-30-2021 06-30-2021 10-Q
19 04-30-2021 03-31-2021 10-Q
20 02-26-2021 12-31-2020 10-K
21 11-04-2020 09-30-2020 10-Q
22 07-31-2020 06-30-2020 10-Q
23 05-01-2020 03-31-2020 10-Q
24 02-26-2020 12-31-2019 10-K
25 11-04-2019 09-30-2019 10-Q
26 07-31-2019 06-30-2019 10-Q
27 05-02-2019 03-31-2019 10-Q
28 02-27-2019 12-31-2018 10-K
29 11-02-2018 09-30-2018 10-Q
30 07-30-2018 06-30-2018 10-Q
31 04-27-2018 03-31-2018 10-Q
32 02-26-2018 12-31-2017 10-K
33 10-27-2017 09-30-2017 10-Q
34 07-31-2017 06-30-2017 10-Q
35 04-28-2017 03-31-2017 10-Q
36 02-27-2017 12-31-2016 10-K
37 11-01-2016 09-30-2016 10-Q
38 07-29-2016 06-30-2016 10-Q
39 05-02-2016 03-31-2016 10-Q
40 02-26-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

rbc-capital-maintains-outperform-on-chemed-lowers-price-target-to-572
RBC Capital Maintains Outperform on Chemed...
11/10/2025 15:31:13

RBC Capital analyst Ben Hendrix maintains Chemed (NYSE:CHE) with a Outperform and lowers the price target from $589 to $572.

caterpillar-posts-upbeat-q3-results-joins-united-therapeutics-centene-fortive-and-other-big-stocks-moving-higher-on-wednesday
Caterpillar Posts Upbeat Q3 Results, Joins...
10/29/2025 14:46:09

chemed-affirms-fy2025-adj-eps-guidance-of-2200-2230-vs-2215-est
Chemed Affirms FY2025 Adj EPS Guidance of ...
10/28/2025 20:18:07

Chemed (NYSE:CHE) affirms FY2025 Adj EPS guidance from $22.00-$22.30 to $22.00-$22.30 vs $22.15 analyst estimate..

chemed-q3-adj-eps-527-misses-536-estimate-sales-624900m-miss-626034m-estimate
Chemed Q3 Adj. EPS $5.27 Misses $5.36 Esti...
10/28/2025 20:17:08

Chemed (NYSE:CHE) reported quarterly earnings of $5.27 per share which missed the analyst consensus estimate of $5.36 by 1.59 p...

earnings-scheduled-for-october-28-2025
Earnings Scheduled For October 28, 2025
10/28/2025 11:11:34

earnings-outlook-for-chemed
Earnings Outlook For Chemed
10/27/2025 18:02:21

b-of-a-securities-maintains-buy-on-chemed-lowers-price-target-to-595
B of A Securities Maintains Buy on Chemed,...
09/10/2025 15:16:50

B of A Securities analyst Joanna Gajuk maintains Chemed (NYSE:CHE) with a Buy and lowers the price target from $610 to $595.

alphabet-to-rally-around-23-here-are-10-top-analyst-forecasts-for-wednesday
Alphabet To Rally Around 23%? Here Are 10 ...
09/03/2025 12:25:40

forecasting-the-future-6-analyst-projections-for-chemed
Forecasting The Future: 6 Analyst Projecti...
09/02/2025 22:02:11

alibaba-to-rally-more-than-12-here-are-10-top-analyst-forecasts-for-tuesday
Alibaba To Rally More Than 12%? Here Are 1...
09/02/2025 12:05:01

this-zscaler-analyst-turns-bullish-here-are-top-4-upgrades-for-tuesday
This Zscaler Analyst Turns Bullish; Here A...
09/02/2025 11:39:34

jefferies-upgrades-chemed-to-buy-raises-price-target-to-550
Jefferies Upgrades Chemed to Buy, Raises P...
09/02/2025 10:06:27

Jefferies analyst Brian Tanquilut upgrades Chemed (NYSE:CHE) from Hold to Buy and raises the price target from $490 to $550.

chemed-board-formally-authorizes-additional-300m-for-stock-repurchase-raises-quarterly-cash-dividend-by-20-from-050-to-060-per-share
Chemed Board Formally Authorizes Additiona...
08/01/2025 16:53:17

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million fo...

rbc-capital-maintains-outperform-on-chemed-lowers-price-target-to-589
RBC Capital Maintains Outperform on Chemed...
07/31/2025 16:04:06

RBC Capital analyst Ben Hendrix maintains Chemed (NYSE:CHE) with a Outperform and lowers the price target from $640 to $589.

heres-how-much-100-invested-in-chemed-15-years-ago-would-be-worth-today
Here's How Much $100 Invested In Chemed 15...
07/31/2025 15:15:28

analyst-expectations-for-chemeds-future
Analyst Expectations For Chemed's Future
07/31/2025 13:00:52

oppenheimer-maintains-outperform-on-chemed-lowers-price-target-to-580
Oppenheimer Maintains Outperform on Chemed...
07/31/2025 12:47:58

Oppenheimer analyst Michael Wiederhorn maintains Chemed (NYSE:CHE) with a Outperform and lowers the price target from $650 t...

chemed-appoints-joel-l-wherley-to-succeed-nicholas-m-westfall-as-vitas-ceo
Chemed Appoints Joel L. Wherley To Succeed...
07/29/2025 20:43:33

After a successful sixteen-year career, Executive Vice President of Chemed and Chairman and Chief Executive Officer of VITAS, N...

chemed-lowers-fy2025-adj-eps-guidance-from-2495-2545-to-2200-2230-vs-2333-est
Chemed Lowers FY2025 Adj EPS Guidance from...
07/29/2025 20:27:42

Chemed (NYSE:CHE) lowers FY2025 Adj EPS guidance from $24.95-$25.45 to $22.00-$22.30 vs $23.33 analyst estimate..

chemed-q2-adj-eps-427-misses-508-estimate-sales-61880m-miss-63403m-estimate
Chemed Q2 Adj. EPS $4.27 Misses $5.08 Esti...
07/29/2025 20:17:31

Chemed (NYSE:CHE) reported quarterly earnings of $4.27 per share which missed the analyst consensus estimate of $5.08 by 15.86 ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION